Infectious Disease Testing

Unprecedented outbreaks of infections and rising awareness of people and policy makers towards the vital use of diagnostic tools are driving the infectious disease diagnostics market. The stringent government regulations constitute barriers for new competitors and control price rise, posing a challenge to the growth of the market.

The reports, books, and subscriptions listed under Research and Markets’ Infectious Disease Testing examine the latest developments across a range of ailments such as HIV/AIDS, HPV and other sexually transmitted diseases, hepatitis, herpes, tuberculosis, and hospital-associated infections. Worth several billion dollars in the US alone, this is a challenging, evolving and highly investible sector. Show Less ... more

• 2013 German Hospital Infectious Disease Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including:  Major issues pertaining...

• 2013 Japanese Hospital Infectious Disease Testing Market

  EURO€ 4,458.00USD$ 5,800.00GBP£ 3,751.00AUD$ 5,673.00JPY¥ 572,651.00SEK 38 082,00CHF 5'467.00CAD$ 5,910.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:  Major issues...

• 2013 Spanish Hospital Infectious Disease Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including:  Major issues...

• 2013 UK Hospital Infectious Disease Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining...

• 2013 US Hospital Infectious Disease Testing Market

  EURO€ 5,227.00USD$ 6,800.00GBP£ 4,397.00AUD$ 6,651.00JPY¥ 671,384.00SEK 44 648,00CHF 6'409.00CAD$ 6,929.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: - Major issues pertaining...

• 2013 French Hospital Infectious Disease Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Dec 2012
  This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including:  Major issues pertaining...

• 2013 Italian Hospital Infectious Disease Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Dec 2012 , Pages: 887
  This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: - Major issues...

• 2013 Pap Smear/HPV Testing Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 243-page report from Venture Planning Group presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical...

• 2013 Vibrio Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 200-page report from Venture Planning Group presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Clostridium Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 225-page report from Venture Planning Group presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 CMV Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 3,728.00USD$ 4,850.00GBP£ 3,136.00AUD$ 4,744.00JPY¥ 478,855.00SEK 31 844,00CHF 4'571.00CAD$ 4,942.00 Venture Planning Group (VPG), Dec 2012
  This new 231-page report from Venture Planning Group presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Coxsackievirus Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 190-page report from Venture Planning Group presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Cryptosporidium Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 207-page report from Venture Planning Group presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current...

• 2013 Cyclospora Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 191-page report from Venture Planning Group presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Echovirus Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  his new 193-page report from Venture Planning Group presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Enterovirus Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 202-page report from Venture Planning Group presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Gonorrhea Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 205-page report from Venture Planning Group presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan Current scientific...

• 2013 Herpes Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 3,728.00USD$ 4,850.00GBP£ 3,136.00AUD$ 4,744.00JPY¥ 478,855.00SEK 31 844,00CHF 4'571.00CAD$ 4,942.00 Venture Planning Group (VPG), Dec 2012 , Pages: 241
  This new 241-page report from Venture Planning Group presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan Current scientific...

• 2013 Mycoplasma Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 202-page report from Venture Planning Group presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Pneumonia Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 197-page report from Venture Planning Group presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Pseudomonas Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 198-page report from Venture Planning Group presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Rabies Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 197-page report from Venture Planning Group presents a detailed analysis of the Rabies diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Rhinovirus Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 194-page report from Venture Planning Group presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Rotavirus Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 205-page report from Venture Planning Group presents a detailed analysis of the Rotavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 RSV Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 227-page report from Venture Planning Group presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan....

• 2013 Yersinia Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 197-page report from Venture Planning Group presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 France Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 27-page report from Venture Planning Group provides an overview of the French infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume...

• 2013 Germany Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 25-page report from Venture Planning Group provides an overview of the German infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume...

• 2013 Italy Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 23-page report from Venture Planning Group provides an overview of the Italian infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume...

• 2013 Japan Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 25-page report from Venture Planning Group provides an overview of the Japanese infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume...

• 2013 Spain Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 19-page report from Venture Planning Group provides an overview of the Spanish infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume...

• 2013 UK Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Venture Planning Group (VPG), Dec 2012
  This new 26-page report from Venture Planning Group provides an overview of the UK infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and...

• 2013 US Infectious Disease Testing Market: Sales Forecasts by Market Segment and Supplier Shares by Test

  EURO€ 653.00USD$ 850.00GBP£ 550.00AUD$ 831.00JPY¥ 83,923.00SEK 5 581,00CHF 801.00CAD$ 866.00 Venture Planning Group (VPG), Dec 2012
  This new 43-page report from Venture Planning Group provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and...

• 2013 Global HIV/AIDS Diagnostics Market: Growth Opportunities and Business Expansion Strategies

  EURO€ 3,728.00USD$ 4,850.00GBP£ 3,136.00AUD$ 4,744.00JPY¥ 478,855.00SEK 31 844,00CHF 4'571.00CAD$ 4,942.00 Venture Planning Group (VPG), Dec 2012
  This new 288-page report from Venture Planning Group presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Adenovirus Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 205-page report from Venture Planning Group presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Aeromonads Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 200-page report from Venture Planning Group presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Campylobacter Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 230-page report from Venture Planning Group presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Chancroid Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 220-page report from Venture Planning Group presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 H. Pylori Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 208-page report from Venture Planning Group presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current...

• 2013 Legionella Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 197-page report from Venture Planning Group presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Lyme Disease Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 203-page report from Venture Planning Group presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Malaria Diagnostics Market: US, Europe, Japan - Test Volume and Sales Forecasts by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 191-page report from Venture Planning Group presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Measles Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 220-page report from Venture Planning Group presents a detailed analysis of the Measles diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Meningitis Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 210-page report from Venture Planning Group presents a detailed analysis of the Meningitis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Mononucleosis Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 200-page report from Venture Planning Group presents a detailed analysis of the Mononucleosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Rubella Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 235-page report from Venture Planning Group presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Salmonella Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 221-page report from Venture Planning Group presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Septicemia Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 202-page report from Venture Planning Group presents a detailed analysis of the Septicemia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Shigella Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 220-page report from Venture Planning Group presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific...

• 2013 Streptococci Diagnostics Market: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Dec 2012
  This new 205-page report from Venture Planning Group presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific...